Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression

J Immunol. 2022 Jul 1;209(1):77-92. doi: 10.4049/jimmunol.2100366. Epub 2022 Jun 15.

Abstract

The zinc-finger transcription factor GATA-3 plays a crucial role during early T cell development and also dictates later T cell differentiation outcomes. However, its role and collaboration with the Notch signaling pathway in the induction of T lineage specification and commitment have not been fully elucidated. We show that GATA-3 deficiency in mouse hematopoietic progenitors results in an early block in T cell development despite the presence of Notch signals, with a failure to upregulate Bcl11b expression, leading to a diversion along a myeloid, but not a B cell, lineage fate. GATA-3 deficiency in the presence of Notch signaling results in the apoptosis of early T lineage cells, as seen with inhibition of CDK4/6 (cyclin-dependent kinases 4 and 6) function, and dysregulated cyclin-dependent kinase inhibitor 2b (Cdkn2b) expression. We also show that GATA-3 induces Bcl11b, and together with Bcl11b represses Cdkn2b expression; however, loss of Cdkn2b failed to rescue the developmental block of GATA-3-deficient T cell progenitor. Our findings provide a signaling and transcriptional network by which the T lineage program in response to Notch signals is realized.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Lineage
  • Cyclin-Dependent Kinase Inhibitor Proteins
  • GATA3 Transcription Factor / metabolism*
  • Gene Regulatory Networks
  • Mice
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Signal Transduction*
  • T-Lymphocytes* / metabolism
  • Tumor Suppressor Proteins / metabolism

Substances

  • Bcl11b protein, mouse
  • Cyclin-Dependent Kinase Inhibitor Proteins
  • GATA3 Transcription Factor
  • Gata3 protein, mouse
  • Repressor Proteins
  • Tumor Suppressor Proteins